Pricing Log in Create free account

Calidi Biotherapeutics, Inc. (CLDI) vs VivoSim Labs, Inc. (VIVS)

Calidi Biotherapeutics, Inc. and VivoSim Labs, Inc. are both Biotechnology companies. Calidi Biotherapeutics, Inc. and VivoSim Labs, Inc. are of similar size ($2.5M and $2.3M). Calidi Biotherapeutics, Inc. has the higher net margin (0.00% vs −11,016.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Calidi Biotherapeutics, Inc. leads on 6 and VivoSim Labs, Inc. on 6.

Valuation

Metric CLDI VIVS Biotechnology median
P/E n/m n/m 10.60
P/S n/m 6.55 9.40
P/B 0.32 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.08 0.08 0.66
EV/Sales n/m (8.35) 9.02
Earnings yield (7,757.14%) (3,192.86%) (32.88%)
Free cash flow yield (1,800.34%) (164.43%) (23.13%)

Profitability

Metric CLDI VIVS Biotechnology median
Gross margin — 100.00% 68.51%
Operating margin 0.00% (10,116.96%) 0.00%
Net margin 0.00% (11,016.07%) 0.00%
Free cash flow margin 0.00% (1,014.29%) 0.00%
Return on equity (900.56%) (343.10%) (51.96%)
Return on assets (283.36%) (155.93%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLDI VIVS Biotechnology median
Revenue growth (TTM) — (21.13%) 6.76%
EPS growth (last fiscal year) 83.31% (214.71%) 29.88%
Revenue growth, 5-year CAGR — (43.10%) 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CLDI VIVS Biotechnology median
Debt to equity 0.24 0.00 0.00
Current ratio 1.68 1.70 4.97
Net debt to EBITDA 0.26 0.45 1.01

Dividend

Metric CLDI VIVS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CLDI VIVS Biotechnology median
Market cap 2.49m 2.34m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack